95 related articles for article (PubMed ID: 10374857)
1. Development of a simple, blood based lymphoproliferation assay to assess the clinical status of patients with acute lymphoblastic leukemia.
Sinha D; Mandal C; Bhattacharya DK
Leuk Res; 1999 May; 23(5):433-9. PubMed ID: 10374857
[TBL] [Abstract][Full Text] [Related]
2. A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatininH: a 9-O-acetyl sialic acid binding lectin.
Sinha D; Bhattacharya DK; Mandal C
Leuk Res; 1999 Sep; 23(9):803-9. PubMed ID: 10475619
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia.
Pal S; Bandyopadhyay S; Chatterjee M; Bhattacharya DK; Minto L; Hall AG; Mandal C
Clin Biochem; 2004 May; 37(5):395-403. PubMed ID: 15087256
[TBL] [Abstract][Full Text] [Related]
4. Identification of 9-O acetyl sialoglycoconjugates (9-OAcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, AchatininH, as a probe.
Sinha D; Mandal C; Bhattacharya DK
Leukemia; 1999 Jan; 13(1):119-25. PubMed ID: 10049046
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: a two-year study with 186 samples following protocol MCP 943.
Bandyopadhyay S; Chatterjee M; Banavali SD; Pal S; Nair CN; Advani SH; Mandal C
Indian J Biochem Biophys; 2006 Feb; 43(1):7-14. PubMed ID: 16955745
[TBL] [Abstract][Full Text] [Related]
6. Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia.
Bandyopadhyay S; Mukherjee K; Chatterjee M; Bhattacharya DK; Mandal C
J Immunol Methods; 2005 Feb; 297(1-2):13-26. PubMed ID: 15777927
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukemia.
Pal S; Ghosh S; Bandyopadhyay S; Mandal C; Bandhyopadhyay S; Kumar Bhattacharya D; Mandal C
Int J Cancer; 2004 Aug; 111(2):270-7. PubMed ID: 15197782
[TBL] [Abstract][Full Text] [Related]
8. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia.
Bandyopadhyay S; Bhattacharyya A; Mallick A; Sen AK; Tripathi G; Das T; Sa G; Bhattacharya DK; Mandal C
Int Immunol; 2005 Feb; 17(2):177-91. PubMed ID: 15629900
[TBL] [Abstract][Full Text] [Related]
9. O-acetyl sialic acid binding lectin as a probe for detection of subtle change on cell surface induced during acute lymphoblastic leukemia (ALL) and its clinical application.
Mandal C; Sinha D; Sharma V; Bhattacharya DK
Indian J Biochem Biophys; 1997; 34(1-2):82-6. PubMed ID: 9343933
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia.
Pal S; Ghosh S; Mandal C; Kohla G; Brossmer R; Isecke R; Merling A; Schauer R; Schwartz-Albiez R; Bhattacharya DK; Mandal C
Glycobiology; 2004 Oct; 14(10):859-70. PubMed ID: 15190007
[TBL] [Abstract][Full Text] [Related]
11. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia.
Mandal C; Mandal C; Chandra S; Schauer R; Mandal C
Glycobiology; 2012 Jan; 22(1):70-83. PubMed ID: 21803834
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
13. O-acetylated sialic acids: multifaceted role in childhood acute lymphoblastic leukaemia.
Chowdhury S; Mandal C
Biotechnol J; 2009 Mar; 4(3):361-74. PubMed ID: 19296441
[TBL] [Abstract][Full Text] [Related]
14. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
[TBL] [Abstract][Full Text] [Related]
15. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.
Pal S; Chatterjee M; Bhattacharya DK; Bandhyopadhyay S; Mandal C
Glycobiology; 2000 Jun; 10(6):539-49. PubMed ID: 10814695
[TBL] [Abstract][Full Text] [Related]
16. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
Savaşan S; Buck S; Ozdemir O; Hamre M; Asselin B; Pullen J; Ravindranath Y
Leuk Lymphoma; 2005 Jun; 46(6):833-40. PubMed ID: 16019527
[TBL] [Abstract][Full Text] [Related]
18. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
19. O-acetylated sialic acid as a distinct marker for differentiation between several leukemia erythrocytes.
Sen G; Chowdhury M; Mandal C
Mol Cell Biochem; 1994 Jul; 136(1):65-70. PubMed ID: 7854333
[TBL] [Abstract][Full Text] [Related]
20. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
